摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3'-(4-chlorophenyl-1,2,3-triazol-1-yl)-3'-deoxy-β-(E)-5-(2-bromovinyl)-2'-deoxyuridine | 1219808-54-4

中文名称
——
中文别名
——
英文名称
3'-(4-chlorophenyl-1,2,3-triazol-1-yl)-3'-deoxy-β-(E)-5-(2-bromovinyl)-2'-deoxyuridine
英文别名
5-[(E)-2-bromoethenyl]-1-[(2R,4S,5S)-4-[4-(4-chlorophenyl)triazol-1-yl]-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
3'-(4-chlorophenyl-1,2,3-triazol-1-yl)-3'-deoxy-β-(E)-5-(2-bromovinyl)-2'-deoxyuridine化学式
CAS
1219808-54-4
化学式
C19H17BrClN5O4
mdl
——
分子量
494.732
InChiKey
MNYPSYJHVXNBMF-CGXZTUQUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    30
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    110
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    4-氯苯乙炔3'-azido-3'-deoxy-β-(E)-5-(2-bromovinyl)-2'-deoxyuridinecopper(ll) sulfate pentahydratesodium ascorbate 作用下, 以 叔丁醇 为溶剂, 反应 24.25h, 以6%的产率得到3'-(4-chlorophenyl-1,2,3-triazol-1-yl)-3'-deoxy-β-(E)-5-(2-bromovinyl)-2'-deoxyuridine
    参考文献:
    名称:
    3′-[4-Aryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidine Analogues as Potent and Selective Inhibitors of Human Mitochondrial Thymidine Kinase
    摘要:
    In an effort to increase the potency and selectivity of earlier identified substrate-based inhibitors of mitochondrial thymidine kinase 2 (TK-2), we now describe the synthesis of new thymidine analogues containing a 4- or 5-substituted 1,2,3-triazol-1-yl substituent at the 3'-position of the 2'-deoxyribofuranosyl ring. These analogues were prepared by Cu- and Ru-catalyzed cycloadditions of 3'-azido-3'-deoxythymidine and the appropriate alkynes, which produced the 1,4- and 1,5-triazoles, respectively. Selected analogues showed nanomolar inhibitory activity for TK-2, while virtually not affecting the TK-1 counterpart. Enzyme kinetics indicated a competitive and uncompetitive inhibition profile against thymidine and the cosubstrate ATP, respectively. This behavior is rationalized by suggesting that the inhibitors occupy the substrate-binding site in a TK-2 ATP complex that maintains the enzyme's active site in a closed conformation through the stabilization of a small lid domain.
    DOI:
    10.1021/jm901532h
点击查看最新优质反应信息